[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.204.108.121. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
September 8, 1999

Sildenafil for Diabetic Men With Erectile Dysfunction

Author Affiliations
 

Margaret AWinkerMD, Deputy EditorIndividualAuthorPhil B.FontanarosaMD, Interim CoeditorIndividualAuthor

JAMA. 1999;282(10):939-941. doi:10-1001/pubs.JAMA-ISSN-0098-7484-282-10-jbk0908

To the Editor: Sildenafil is being used extensively for erectile dysfunction (ED) of all causes, due to its inhibitory effect on cyclic guanosine monophosphate (GMP) phosphodiesterase in the corpus cavernosum of the penis.1 Most patients with diabetes have ED due to either vascular abnormalities or neuropathy. Impaired nitric oxide synthesis may be an important factor in these patients and, therefore, conservation of cyclic GMP by sildenafil is an effective mechanism to enhance nitric oxide bioavailability and thereby improve erections. Dr Rendell and colleagues2 do not explain their finding that men with diabetes had a lower response rate to sildenafil than that previously reported in mixed, largely nondiabetic populations. Diabetic men may have sex hormone abnormalities that could interfere with their response to sildenafil, but Rendell et al did not report the sex hormone levels in their patients.

First Page Preview View Large
First page PDF preview
First page PDF preview
×